HOFSETH BIOCARE ASA: årsregnskap 2013 vs 2012
Grew 141% on revenue, stronger earnings, fresh owner capital
approved 2014-04-30; registry 2014-06-16; journal 2014 456507
Summary
What changed
Comparing Årsregnskap 2013 with 2012 for HOFSETH BIOCARE ASA. Revenue 26.02m NOK → 62.69m NOK (+141.0%). Net result -73.86m NOK → -52.13m NOK. Equity 48.47m NOK → 69.20m NOK.
On the constructive side: revenue rose; net result improved; equity strengthened.
Also worth watching: cogs moved. All figures are taken from the published annual accounts for HOFSETH BIOCARE ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 26.02m NOK to 62.69m NOK (+141.0% YoY). Calculated
-
↑
Net result improved
Net result -73.86m NOK → -52.13m NOK (net margin -283.9% → -83.2%). Calculated
-
↑
Equity strengthened
Book equity 48.47m NOK → 69.20m NOK (equity ratio 31.2% → 35778.0%). Calculated
-
↑
Cash rose
Bank deposits 0 NOK → 3.79m NOK (None YoY). Calculated
-
↑
Current ratio back above 1×
Current ratio 0.30× → 1.16×. Calculated
Things to notice
-
·
COGS moved
COGS / varekostnad 24.6k NOK → 29.85m NOK (+121435.0% YoY). Calculated